The landscape of diabetes care is changing with the emergence of skin-applied GLP-1 therapy. These novel patches offer a possibly more comfortable alternative to injections for individuals managing type 2 diabetes . These patches deliver a GLP-1 agonist directly through the dermis , bypassing the